HINJ salutes the work of the life sciences industry during this unprecedented pandemic.
“Today’s rollout in New Jersey of the Pfizer and BioNTech vaccine for COVID-19 to health care workers is a major step forward in the effort to combat this pandemic,” said Dean J. Paranicas, president and chief executive officer of HINJ. “And with additional vaccine approvals on the horizon, we have hope that it will be arrested soon.”
“HINJ is proud to represent companies that have dedicated themselves for the past year to developing testing, therapeutics and now a vaccine to identify, treat and prevent COVID-19, the greatest public health threat in a century,” Paranicas added. “The work of our member companies illustrates why New Jersey has long been known as a leading global innovation hub and as ‘the medicine chest of the world.’”